Top news of the week: 18.08.2020.
#biotechnology #biospace #lifesciences #pharmaceuticals #COVID #treatment #vaccine #COVID19 #coronavirus #pandemic
Career And Jobs
How to Jumpstart Your Job Search Strategy
#biospace #lifesciences #biotechnology #pharmaceuticals
#careers #careeradvice #jobs #resume #communication
https://t.co/9dEklCEpEw
OpenHow to Jumpstart Your Job Search Strategy
Whether you’re an experienced professional in the field or just embarking on your new career, it’s time to look at your qualifications and career plans from an entirely different ...
Biopharma Update on the Novel Coronavirus: August 12
#biospace #lifesciences #biotechnology #pharmaceuticals
#COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/y2pKxN1Dxs
OpenBiopharma Update on the Novel Coronavirus: August 12
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 12, 2020.
With so much Covid-19 infection asymptomatic, many see surveillance testing as key to keeping employees safe. One biotech CEO put together a system for 50 companies that returns results in a median of 12 hours. https://t.co/1wACuFTROo
OpenHow a biotech CEO figured out Covid-19 surveillance testing for 50 companies with 12-hour turnaround times
As testing turnaround times stretch to a week or more for some parts of the country, a group of 50 biotech companies has figured out a surveillance system with results in 12 hours.
Sanofi Acquires Principia Biopharma in $3.6 Billion Deal
#biospace #lifesciences #biotechnology #pharmaceuticals
https://t.co/0o67bd4Keq
OpenSanofi Acquires Principia Biopharma in $3.6 Billion Deal
Under terms of the deal, Sanofi will acquire all of the outstanding shares of Principia for $100 per share in cash, which represents an aggregate equity value of approximately $3.68 ...
Biopharma Update on the Novel Coronavirus: August 14
#biospace #lifesciences #biotechnology #pharmaceuticals
#COVID-19 #coronavirus #pandemic #COVID19 #treatment #vaccine
https://t.co/B7n6PedR9S
OpenBiopharma Update on the Novel Coronavirus: August 14
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 14, 2020.
Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd.
https://t.co/dFVjPclnzi
#news #pharma #pharmiweb
OpenBayer to acquire UK-based biotech KaNDy Therapeutics Ltd.
• Further expansion of Bayer’s drug development pipeline in Women’s Healthcare• Non-hormonal oral compound NT-814 to alleviate menopausal symptoms• Development ...
BioMarin CSO disses rivals for the hemophilia A gene therapy crown: Way behind, facing big recruitment challenges and at best a .6 on the gen-one scale
$BMRN $SGMO
https://t.co/McwTwCgVoH
OpenBioMarin CSO disses rivals for the hemophilia A gene therapy crown: Way behind, facing big recruitment challenges and at best a .6 on the gen-one scale
The leader in the race to a hemophilia A gene therapy does not like to be compared unfavorably to the competition. And when their top execs do the comparing, don't look for any modesty — ...
The FDA just approved the third Duchenne MD drug. And regulators still don’t know if any of them work
@MaxGelman
https://t.co/z8rLczCnaD
OpenThe FDA just approved the third Duchenne MD drug. And regulators still don’t know if any of them work
Last year Sarepta hit center stage with the FDA’s controversial reversal of its CRL for the company's second Duchenne muscular dystrophy drug -- after the biotech was ambushed by agency ...